Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients

Authors: Lin-sen Feng, Xin-yue Li, Hong-rong Wang, Jing-jing Zhan, Dong Chen, Yu-feng Wang

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

To develop a Cancer Self-Perceived Discrimination Scale (CSPDS) for Chinese cancer patients and to assess its reliability and validity.

Method

A total of 178 patients were recruited and the classical test theory was used to develop the CSPDS. Item analysis was adapted to improve the preliminary version of the CSPDS, then the reliability, the validity and the acceptability of the final version of CSPDS were assessed.

Results

This CSPDS contained 14 items classified into 3 subscales: social withdrawal with 7 items, stigma with 4 and self-deprecation with 3. Good validity (χ2/df = 1.216, GFI = 0.935, AGFI = 0.903, I-CVIs> 0.80) and good reliability (Cronbach’s alpha = 0.829, Spearman-Brown coefficient = 0.827, test-retest reliability coefficient = 0.944) were found. The completion time was 6.06 ± 1.80 min. Participants who were female and reported poor self-rated health tended to have higher CSPDS scores (P <  0.05).

Conclusions

The results indicated that this CSPDS could be used to assess the level of self-perceived discrimination and to preliminarily screen perceived discrimination among Chinese cancer patients, especially in Southwest China. It may provide a basis for scientific assessment of targeted patient education, psychological counseling, social interventions, and psychotherapy in the future.
Literature
1.
2.
3.
Gil-González D, Vives-Cases C, Borrell C, et al. Social determinants of self-perceived discrimination in Spain. Public Health. 2013;127:223–30.CrossRefPubMed
4.
Feng D, Xu L. The relationship between perceived discrimination and psychological distress among Chinese pulmonary tuberculosis patients: the moderating role of self-esteem. Psychol Health Med. 2015;20:177–85.CrossRefPubMed
5.
Xiaoyou S, Lau JTF, Mak WWS, et al. Perceived discrimination, social support, and perceived stress among people living with HIV/AIDS in China. AIDS Care. 2013;25:239–48.CrossRef
6.
Brakel WHV, Sihombing B, Djarir H, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Glob Health Action. 2012;5:18394.CrossRef
7.
Genberg BL, Kawichai S, Chingono A, et al. Assessing HIV/AIDS stigma and discrimination in developing countries. AIDS Behav. 2008;12:772–80.CrossRefPubMed
8.
Antonio L, Silvia Z, Tine VB, et al. Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey. Lancet. 2013;381:55–62.CrossRef
9.
Bifftu BB, Dachew BA, Tiruneh BT. Stigma resistance among people with schizophrenia at Amanuel mental specialized hospital Addis Ababa, Ethiopia: a cross-sectional institution based study. BMC Psychiatry. 2014;14:259.CrossRefPubMedPubMedCentral
10.
Harriet D, Andrew B. Commentary: factors affecting HIV/AIDS-related stigma and discrimination by medical professionals. Int J Epidemiol. 2007;36:185–6.CrossRef
11.
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMed
12.
13.
Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577–92.CrossRefPubMed
14.
Vos MS, Putter H, Houwelingen HCV, et al. Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial. Lung Cancer. 2011;72:119–24.CrossRefPubMed
15.
16.
Mosher CE, Sharon DB. Death anxiety and cancer-related stigma: a terror management analysis. Death Stud. 2007;31:885–907.CrossRefPubMed
17.
Phelan SM, Griffin JM, Jackson GL, et al. Stigma, perceived blame, self-blame, and depressive symptoms in men with colorectal cancer. Psychooncology. 2013;22:65–73.CrossRefPubMed
18.
Jennifer MS, Ubel PA, Atisha DM, et al. The choice for breast cancer surgery: can women accurately predict postoperative quality of life and disease-related stigma? Ann Surg Oncol. 2011;18:2477–82.CrossRef
19.
Rosman S. Cancer and stigma: experience of patients with chemotherapy-induced alopecia. Patient Educ Couns. 2004;52:333–9.CrossRefPubMed
20.
Stergiou-Kita M, Pritlove C, Kirsh B. The “Big C”—stigma, cancer, and workplace discrimination. J Cancer Surviv. 2016;10:1–16.CrossRef
21.
Allain DC, Friedman S, Senter L. Consumer awareness and attitudes about insurance discrimination post enactment of the genetic information nondiscrimination act. Familial Cancer. 2012;11:637–44.CrossRefPubMed
22.
Huizenga CR, Lowstuter K, Banks KC, et al. Evolving perspectives on genetic discrimination in health insurance among health care providers. Familial Cancer. 2010;9:253–60.CrossRefPubMed
23.
Cataldo JK, Slaughter R, Jahan TM, et al. Measuring stigma in people with lung cancer: psychometric testing of the Cataldo lung cancer stigma scale. Oncol Nurs Forum. 2011;38:E46–54.CrossRefPubMedPubMedCentral
24.
Kissane DW, Patel SG, Baser RE, et al. Preliminary evaluation of the reliability and validity of the shame and stigma scale in head and neck cancer. Head Neck. 2013;35:172–83.CrossRefPubMed
25.
Bao Y, Pan S. Differences-seeking Approach in Qualitative Method and Its Theoretical Foundation. Sociol Rev China. 2015;3:89–96. (in Chinese)
26.
27.
Barney LJ, Griffiths KM, Christensen H, et al. The self-stigma of depression scale (SSDS): development and psychometric evaluation of a new instrument. Int J Methods Psychiatr Res. 2010;19:243–54.CrossRefPubMed
28.
Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006;29:489–97.CrossRefPubMed
29.
Gorsuch RL. Factor analysis (2nd ed.). Hillsdale: Erlbaum; 1983.
30.
MacCallum RC, Widaman KF, Zhang S, et al. Sample size in factor analysis. Psychol Methods. 1999;4:84–99.CrossRef
31.
32.
Zhao Q, Yang L, Zuo Q, et al. Instrument development and validation of the stroke pre-hospital delay behavior intention scale in a Chinese urban population. Health Qual Life Outcomes. 2014;12:170.CrossRefPubMedPubMedCentral
33.
Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess. 1995;7:309–19.CrossRef
34.
Hendriks JM, Crijns HJ, Tieleman RG, et al. The atrial fibrillation knowledge scale: development, validation and results. Int J Cardiol. 2013;168:1422–8.CrossRefPubMed
35.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
36.
Cataldo JK, Brodsky JL. Lung cancer stigma, anxiety, depression and symptom severity. Oncology. 2013;85:33–40.CrossRefPubMed
37.
Tang Y, Luo W. Investigation on family status of women in poor rural areas—With Tongwei county in Dingxi of Gansu as an example. J Univ Sci Technol Beijing (Soc Sci Ed). 2014;30:46–55. (in Chinese)
38.
Zhang C, Lei X, Strauss J, et al. Health insurance and health care among the mid-aged and older Chinese: evidence from the national baseline survey of CHARLS. Health Econ. 2017;26:431–49.CrossRefPubMed
39.
Bouskill K, Kramer M. The impact of cancer and quality of life among long-term survivors of breast cancer in Austria. Support Care Cancer. 2016;24:4705–12.CrossRefPubMed
Metadata
Title
Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients
Authors
Lin-sen Feng
Xin-yue Li
Hong-rong Wang
Jing-jing Zhan
Dong Chen
Yu-feng Wang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-0984-x

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue

Research

Translation and validation of the French version of the Child Perceptions Questionnaire for children aged from 8 to 10 years old (CPQ 8-10)

Research

Physical frailty characteristics have a differential impact on symptoms as measured by the CAT score: an observational study

Research

Can practitioners use patient reported measures to enhance person centred coordinated care in practice? A qualitative study

Research

Psychometric characteristics of the FertiQoL questionnaire in a German sample of infertile individuals and couples.

Research

The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: a cross-sectional study

Research

Adaption and validation of the nasal obstruction symptom evaluation scale in German language (D-NOSE)